Category Archives: Ulcerative Colitis

My Ulcerative Colitis Story I was diagnosed with Ulcerative Colitis I was discharged from hospital not long ago I still have a long way to go but wit god by my side thing will get better. By: LeeDonghae'sWIFE … Continue reading →

Peoria Connections Interview - Successes with autoimmune disease, ADHD, ulcerative colitis Are you battling a chronic autoimmune disease, digestive disorder, bloating, ADHD, memory loss, sleep challenges, low thyroid or more? Follow this interview ... By: Renovare Wellness By Design … Continue reading →

Crohns Disease Ulcerative Colitis The Diagnosing Difficulties This is Video 5 of 8 from my September 15, 2014 interview w/ Dr. Mark L. Chapman of Mount Sinai Hospital in New York City and focuses on the too-often long, ... By: Michael Weiss … Continue reading →

Healing my Ulcerative Colitis This is my story in how I am taking a positive approach and helping to heal my Ulcerative Colitis. I am doing this all by clean eating and being conscious of... By: Dena Tognotti … Continue reading →

My Ulcerative Colitis Diet Just sharing my Colitis food dos and don'ts! 🙂 This was recorded this morning! (10-28-14) ~~~ My Facebook page: https://www.facebook.com/jenniesymsickart?re... By: emokitten6871 … Continue reading →

Managing Ulcerative Colitis Naturally: Outlook Perspective This might be the most important element to managing Ulcerative Colitis (or any chronic disease) naturally. (open me for goodies!) My background with UC: http://youtu.be/ojdrFyOcxKk Nick... By: SarahBethYoga … Continue reading →

Justin Mirigliani repping 260lbs on the Bench! Never Surrender! Fighting Ulcerative Colitis! Justin Mirigliani training for the game against the Flyers Alumni on January 10, 2015 in Aston, PA. Not quite where I want to be, but getting there! For more information go to: http://www.checkmatescharit... By: Justin Mirigliani … Continue reading →

By Estel Grace Masangkay The Scripps Research Institute (TSRI) reported that results from the Phase 2 study of RPC1063, a drug discovered at the Institute, show RPC1063s potential in the treatment of ulcerative colitis (UC). RPC1063 is a sphingosine 1-phosphate 1 receptor (S1P1R) small molecule modulator drug candidate being investigated for immune indications. These include relapsing multiple sclerosis (RMS) and inflammatory bowel disease (IBD), under which ulcerative colitis is categorized along with Crohns disease. RPC1063 was derived from a screening hit conducted at the National Institutes of Health molecular library at Scripps Florida's Molecular Screening Center, after which it was licensed to Receptos for further development. Receptos reported positive results from a Phase 2 trial of the drug in relapsing multiple sclerosis earlier this year. The double blind, randomized, placebo-controlled TOUCHSTONE trial investigated the safety, tolerability, and efficacy of RPC1063 in patients with UC. The drug met the trials primary endpoint, which was proportion of patients in clinical remission at week 8 compared to placebo. Secondary endpoints were also met, including clinical response, change from baseline, and mucosal improvement on endoscopy. The company said it will present detailed results of the trial at an upcoming major scientific meeting. We are … Continue reading →

Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute (TSRI). According to results released today from a Phase 2 study of 199 patients with active, moderate to severe disease, the drug candidate RPC1063 has potential to significantly improve the treatment paradigm for ulcerative colitis patients. The latest results show that, after eight weeks of treatment with a 1 mg dose of RPC1063, 16.4 percent of patents were in clinical remission, as compared to 6.2 percent of patients on placebo. "We are delighted that RPC1063 is showing promise for ulcerative colitis patients in addition to its already significant efficacy and safety data in multiple sclerosis," said TSRI Professor Hugh Rosen, who together with Professor Ed Roberts led the team that discovered RPC-1063. "Research carried out at TSRI since 2002 has led to the discovery of fundamental mechanisms that can be modulated for potential treatments of a variety of autoimmune diseases including ulcerative colitis and multiple sclerosis, and the unique multidisciplinary environment in chemistry and biology at TSRI allowed this progression to clinical trials." The clinical trial, sponsored by Receptos, Inc., the San Diego biotechnology company … Continue reading →

Should I Drink Alcohol if I Have Crohn's Disease or Ulcerative Colitis I get asked a lot if I drink while having Crohn's Disease, or I if it is okay. My answer is to "Ask your doctor, and check the label on your medicines." I on... By: Crohnsfighter My Fight Against Crohn's … Continue reading →